STAAR Surgical (NASDAQ:STAA) Major Shareholder Acquires $1,633,394.96 in Stock

STAAR Surgical (NASDAQ:STAA) major shareholder Broadwood Partners, L.P. acquired 93,124 shares of the company’s stock in a transaction dated Tuesday, March 18th. The stock was acquired at an average price of $17.54 per share, with a total value of $1,633,394.96. Following the purchase, the insider now owns 12,074,275 shares in the company, valued at approximately $211,782,783.50. This represents a 0.78 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Major shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

Broadwood Partners, L.P. also recently made the following trade(s):

• On Thursday, March 20th, Broadwood Partners, L.P. bought 108,720 shares of STAAR Surgical stock. The shares were purchased at an average price of $17.96 per share, with a total value of $1,952,611.20.
• On Monday, March 3rd, Broadwood Partners, L.P. acquired 249,503 shares of STAAR Surgical stock. The shares were bought at an average cost of $16.64 per share, for a total transaction of $4,151,729.92.
• On Thursday, February 27th, Broadwood Partners, L.P. acquired 259,316 shares of STAAR Surgical stock. The shares were bought at an average cost of $17.05 per share, for a total transaction of $4,421,337.80.
• On Friday, February 14th, Broadwood Partners, L.P. acquired 36,532 shares of STAAR Surgical stock. The shares were bought at an average cost of $15.49 per share, for a total transaction of $565,880.68.
• On Wednesday, February 12th, Broadwood Partners, L.P. acquired 259,616 shares of STAAR Surgical stock. The shares were bought at an average cost of $14.96 per share, for a total transaction of $3,883,855.36.
• On Thursday, January 16th, Broadwood Partners, L.P. acquired 8,221 shares of STAAR Surgical stock. The shares were bought at an average cost of $21.50 per share, for a total transaction of $176,751.50.
• On Tuesday, January 14th, Broadwood Partners, L.P. acquired 21,155 shares of STAAR Surgical stock. The shares were bought at an average cost of $21.46 per share, for a total transaction of $453,986.30.

STAAR Surgical Trading Down 1.8 %

Shares of NASDAQ:STAA traded down $0.33 during mid-day trading on Thursday, reaching $17.92. The stock had a trading volume of 1,073,972 shares, compared to its average volume of 760,650. STAAR Surgical has a twelve month low of $13.50 and a twelve month high of $52.68. The firm has a 50 day simple moving average of $19.97 and a two-hundred day simple moving average of $25.81. The firm has a market cap of $883.90 million, a PE ratio of -43.71 and a beta of 0.66.

Analysts Set New Price Targets

Several research analysts have recently issued reports on the stock. William Blair lowered shares of STAAR Surgical from an “outperform” rating to a “market perform” rating in a research note on Wednesday, February 12th. Canaccord Genuity Group reduced their target price on shares of STAAR Surgical from $28.00 to $17.00 and set a “hold” rating on the stock in a research note on Thursday, February 13th. Stifel Nicolaus reduced their target price on shares of STAAR Surgical from $38.00 to $20.00 and set a “buy” rating on the stock in a research note on Wednesday, February 12th. Mizuho lowered shares of STAAR Surgical from an “outperform” rating to a “neutral” rating and reduced their target price for the company from $45.00 to $17.00 in a research note on Wednesday, February 12th. Finally, StockNews.com lowered shares of STAAR Surgical from a “hold” rating to a “sell” rating in a research note on Thursday, February 13th. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat.com, STAAR Surgical has an average rating of “Hold” and a consensus target price of $25.29.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the stock. Quarry LP bought a new position in STAAR Surgical in the third quarter valued at approximately $50,000. Quest Partners LLC bought a new stake in shares of STAAR Surgical in the third quarter worth $128,000. Larson Financial Group LLC lifted its position in shares of STAAR Surgical by 78.3% in the third quarter. Larson Financial Group LLC now owns 4,863 shares of the medical instruments supplier’s stock worth $181,000 after purchasing an additional 2,135 shares in the last quarter. FMR LLC lifted its position in shares of STAAR Surgical by 79.3% in the third quarter. FMR LLC now owns 7,092 shares of the medical instruments supplier’s stock worth $263,000 after purchasing an additional 3,136 shares in the last quarter. Finally, KLP Kapitalforvaltning AS acquired a new position in STAAR Surgical during the fourth quarter worth $180,000. Institutional investors own 96.70% of the company’s stock.

About STAAR Surgical

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.